Piperacillin-tazobactam/meropenem vs colistin/meropenem for carbapenem-resistant Klebsiella Pneumoniae-related ventilator-associated pneumonia. [PDF]
Shadravan MM +5 more
europepmc +1 more source
Enhanced meropenem activity by a microbiome derived peptide targeting oxacillinase 48 carbapenemase in carbapenem resistant Klebsiella pneumoniae isolates. [PDF]
Sadeghi S, Faramarzi MA, Siroosi M.
europepmc +1 more source
Study on the heteroresistance of carbapenem-resistant Klebsiella pneumoniae to Tigecycline and Polymyxin B and antibacterial activity of combined drugs in vitro. [PDF]
Dong Y, Hu Z, Yang L, Kong H, Xu Y.
europepmc +1 more source
Epidemiology and genomic characteristics of carbapenem-resistant Klebsiella pneumoniae in intensive care unit from 2021 to 2024. [PDF]
Ma Z +7 more
europepmc +1 more source
Correlation between antimicrobial resistance and virulence in carbapenem-resistant Klebsiella pneumoniae at colonization and infection stages. [PDF]
He J +7 more
europepmc +1 more source
Mortality markers in nosocomial Klebsiella pneumoniae bloodstream infection [PDF]
Bilge Gultepe +5 more
core +1 more source
Clinical characteristics and molecular epidemiology of KPC-NDM co-producing carbapenem-resistant Klebsiella pneumoniae in China: a multicentre retrospective case-control study. [PDF]
Li X +19 more
europepmc +1 more source
Microbiome-mediated colonization resistance to carbapenem-resistant Klebsiella pneumoniae in ICU patients. [PDF]
Yang J +20 more
europepmc +1 more source
Epidemiological and genomic profiles of NDM-1-Producing ST25-KL2 carbapenem-resistant Klebsiella pneumoniae among pediatric patients in Hangzhou, China. [PDF]
Zhang X +7 more
europepmc +1 more source
Safety and therapeutic potential evaluation of Cefotaxime plus Polymyxin B against polymyxin-carbapenem resistant Klebsiella pneumoniae in a murine model. [PDF]
Sturaro MC +11 more
europepmc +1 more source

